SK Biopharmaceuticals Co., Ltd. (KRX:326030)
124,600
-900 (-0.72%)
At close: Dec 30, 2025
20.04% (1Y)
| Market Cap | 9.76T |
| Revenue (ttm) | 675.41B |
| Net Income (ttm) | 320.47B |
| Shares Out | 78.31M |
| EPS (ttm) | 4,092.19 |
| PE Ratio | 30.45 |
| Forward PE | 39.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 99,454 |
| Average Volume | 174,785 |
| Open | 126,100 |
| Previous Close | 125,500 |
| Day's Range | 123,900 - 126,400 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.84 |
| RSI | 38.64 |
| Earnings Date | Feb 4, 2026 |